RIKEN Center for Integrative Medical Sciences

RIKEN Center for Integrative Medical Sciences
Name	RIKEN Center for Integrative Medical Sciences
Established	2005
Type	Research institute
City	Yokohama
Country	Japan

RIKEN Center for Integrative Medical Sciences. The center is a biomedical research institute located in Yokohama that integrates genomics, proteomics, bioinformatics, and clinical science through multidisciplinary teams drawn from institutions such as University of Tokyo, Kyoto University, Osaka University, Tohoku University, and Nagoya University. It occupies a role in national and international consortia with partners including National Institutes of Health, Wellcome Trust, European Molecular Biology Laboratory, Harvard University, and Stanford University, supporting translational programs that bridge basic research and clinical application.

History

The center traces its roots to RIKEN reorganizations in the early 2000s and formal establishment in 2005 amid restructuring that involved units transferred from facilities like the Institute of Physical and Chemical Research and initiatives linked to the Ministry of Education, Culture, Sports, Science and Technology (Japan). Early collaborations connected the center with projects such as the Human Genome Project, the 1000 Genomes Project, and the International HapMap Project, while notable visiting scientists from Cold Spring Harbor Laboratory, Max Planck Society, and Salk Institute influenced its trajectory. The center has since evolved through strategic ties to consortia led by European Bioinformatics Institute, National Center for Biotechnology Information, and national research centers like National Cancer Center (Japan) and National Center for Neurology and Psychiatry (Japan).

Organization and Leadership

Organizational leadership has included directors and principal investigators recruited from institutions such as Kyushu University, Hokkaido University, Keio University, Nippon Medical School, and Chiba University. Governance structures mirror those at institutes like Mayo Clinic, Massachusetts General Hospital, and Johns Hopkins University School of Medicine, incorporating advisory boards with members from Imperial College London, Karolinska Institutet, ETH Zurich, and University of Cambridge. Administrative relationships extend to funding bodies such as Japan Science and Technology Agency, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, and international funders including Gates Foundation and Japan Bank for International Cooperation.

Research Programs and Facilities

Programs emphasize integrative approaches in genomics, metabolomics, proteomics, structural biology, and systems medicine, paralleling endeavors at Broad Institute, European Molecular Biology Laboratory, Rudolf Magnus Institute, and Weizmann Institute of Science. Facilities house high-throughput sequencers comparable to platforms used by Illumina, cryo-electron microscopes seen at EMBL Grenoble, mass spectrometers analogous to those at Max Planck Institute for Biophysical Chemistry, and biobanks coordinated with UK Biobank and All of Us Research Program. Core units include computational biology groups using resources like Super-K computer, clusters similar to Fugaku, and databases interoperable with GenBank, Ensembl, dbSNP, and UniProt.

Major Projects and Collaborations

Major projects encompass population genomics studies linked to Tohoku Medical Megabank Project, precision medicine initiatives parallel to Precision Medicine Initiative (United States), and disease-specific consortia focusing on oncology, neurology, and immunology with partners such as MD Anderson Cancer Center, Dana-Farber Cancer Institute, Rett Syndrome Research Trust, Alzheimer’s Disease Neuroimaging Initiative, and Paul Ehrlich Institute. International collaborations involve exchanges with NIH Clinical Center, CERN (for big data analytics), European Commission Horizon 2020, Bill & Melinda Gates Foundation Grand Challenges, and bilateral programs with Chinese Academy of Sciences, Korea Advanced Institute of Science and Technology, and Institut Pasteur. The center has participated in large-scale efforts like the Human Cell Atlas, the Cancer Genome Atlas, and multi-omics consortia similar to work at Stanford Medicine and UCSF.

Publications and Contributions to Medicine

Researchers have published in journals such as Nature, Science, Cell, The Lancet, New England Journal of Medicine, Nature Genetics, Nature Medicine, and Genome Research, contributing to discoveries in genetic risk loci, biomarker discovery, and therapeutic target identification linked to diseases studied at St. Jude Children’s Research Hospital, Cleveland Clinic, and Riken BRC. Contributions include development of analytical pipelines compatible with GATK, novel algorithms akin to those from Broad Institute, and datasets integrated into resources like Human Protein Atlas and Gene Expression Omnibus. Work from the center has informed clinical guidelines used by institutions such as Japanese Circulation Society, American Heart Association, and European Society of Cardiology.

Education, Training, and Outreach

Training programs mirror postgraduate initiatives at University of Oxford, Yale University, Columbia University, and University of California, Berkeley with joint-phD tracks, postdoctoral fellowships, and clinician-scientist pathways involving World Health Organization advisory activities and capacity building with Asian Development Bank-funded programs. Outreach includes symposia co-hosted with Gordon Research Conferences, workshops with EMBO, and public engagement in partnership with museums like Edo-Tokyo Museum and science festivals similar to Japan Science Festival. The center also collaborates on policy discussions alongside OECD, United Nations Educational, Scientific and Cultural Organization, and professional societies such as American Society of Human Genetics and International Society for Computational Biology.

Category:Research institutes in Japan